Research of safety and efficacy of percutaneous vertebroplasty for fragile bone lesions due to metastatic bone tumor or osteoporosis

Research of safety and efficacy of percutaneous vertebroplasty for fragile bone lesions due to metastatic bone tumor or osteoporosis - Research of safety and efficacy of percutaneous vertebroplasty

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004870

Enrollment

Registered

2011-01-13

Start date

2010-01-01

Completion date

Unknown

Last updated

2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who are suitable for this therapy if some conditions are right.

Interventions

percutaneous vertebroplasty

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria: Patients with acute infection, hemorrhagic tendency, severe cardiopulmonary disorder, severe obesity, hypovolemic state, or the presumable occurence of adverse effects.

Design outcomes

Primary

Measure	Time frame
To estimate the occurence rate of adverse effects of vertebroplasty.	—

Secondary

Measure	Time frame
To estimate the pain relief rate and the reduction rate of pain medicine use.	—

Countries

Japan

Contacts

Public ContactTomoyuki Noguchi

Saga University Dept of Radiology

tonoguti@cc.saga-u.ac.jp0952-34-2309

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 4, 2026